Hypocomplementemic Atypical IgA Vasculitis: A Case Report

IgA vasculitis (IgAV, also known as Henoch-Schönlein purpura or HSP) is a vasculitis of small vessels involving multiple organs, particularly of the joints, gastrointestinal tract, skin, and kidneys. Growing laboratory evidence has shown that complement plays a key role in the pathogenesis of IgAV, although direct evidence of this association in patients is lacking. We report a child with IgAV associated with clinical features of hypertension, nephrotic range proteinuria, acute kidney injury, and low serum C3, with histopathologic findings on renal biopsy of membranoproliferative glomerulonephritis with C3 and IgA co-dominance, and extensive complement derangements. This case report suggests that complement modifies the pathogenesis of IgAV, and further investigation into complement-targeted therapy in cases of refractory IgAV may be beneficial.

[1]  Hong Zhang,et al.  Collectin11 and Complement Activation in IgA Nephropathy , 2021, Clinical journal of the American Society of Nephrology : CJASN.

[2]  M. Szczepańska,et al.  IgA vasculitis with nephritis in children. , 2020, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[3]  S. Ozen,et al.  Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used? , 2019, Pediatric Rheumatology.

[4]  G. Remuzzi,et al.  Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN , 2018, Front. Immunol..

[5]  A. Gharavi,et al.  Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[6]  Yusuke Suzuki,et al.  IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. , 2018, Kidney international.

[7]  F. Berthoux,et al.  Deletion Variants of CFHR1 and CFHR3 Associate with Mesangial Immune Deposits but Not with Progression of IgA Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[8]  John D Lambris,et al.  The renaissance of complement therapeutics , 2018, Nature Reviews Nephrology.

[9]  T. Cavero,et al.  Effectiveness of mycophenolate mofetil in C3 glomerulonephritis. , 2015, Kidney international.

[10]  D. Karpman,et al.  Eculizumab treatment for rescue of renal function in IgA nephropathy , 2014, Pediatric Nephrology.

[11]  V. D’Agati,et al.  C3 glomerulopathy: consensus report , 2013, Kidney international.

[12]  T. Yoo,et al.  Decreased Circulating C3 Levels and Mesangial C3 Deposition Predict Renal Outcome in Patients with IgA Nephropathy , 2012, PloS one.

[13]  Xiaozhong Li,et al.  Henoch–Schönlein purpura with hypocomplementemia , 2012, Pediatric Nephrology.

[14]  J. Davin Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[15]  B. Preston,et al.  Case Series , 2010, Toxicologic pathology.

[16]  L. Jara,et al.  Hypocomplementemic urticarial vasculitis syndrome , 2009, Current rheumatology reports.

[17]  D. Cattran,et al.  Remission of resistant MPGN type I with mycophenolate mofetil and steroids , 2009, Pediatric Nephrology.

[18]  T. Ha,et al.  A Case of Hypocomplementemic Henoch-Schonlein Purpura Presenting Features of Membranoproliferative Glomerulonephritis , 2005 .

[19]  M. Harber,et al.  Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  S. Mrusek,et al.  Henoch-Schönlein purpura , 2004, The Lancet.

[21]  C. Dilber,et al.  Is low serum complement 3 in Henoch Schönlein purpura unusual and of prognostic value? , 2001, European Journal of Pediatrics.

[22]  I. T. Ten Berge,et al.  What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? , 2001, Kidney international.

[23]  H. Tamary,et al.  Low serum C3, leukopenia, and thrombocytopenia: unusual features of Henoch-Schonlein purpura , 1999, European Journal of Pediatrics.

[24]  J. Feehally,et al.  Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  B. Pipy,et al.  Henoch-Schönlein purpura and membranoproliferative-like glomerulonephritis. , 1996, Nephron.

[26]  I A Mjör,et al.  Consensus Report , 1985, Journal of dental research.

[27]  C. Chantler,et al.  Serum complement components in Henoch-Schönlein purpura. , 1978, Archives of disease in childhood.